Literature DB >> 2162558

Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir.

T Bergström1, K Alestig.   

Abstract

We describe therapy with acyclovir in 1 patient with acute meningitis induced by herpes simplex virus type 2 (HSV-2) and in 1 patient with ascending myelitis in connection with meningitis after a primary genital HSV-2 infection. In addition, intermittent or continuous acyclovir prophylaxis against meningitis was employed in 3 patients with recurrent meningitis of probable HSV-2 etiology. Possible beneficial effects of the treatment were seen.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2162558     DOI： 10.3109/00365549009037909

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  11 in total

1.  Chronic meningitis due to herpes simplex virus in an immunocompetent host.

Authors:  R H Chin; B C Ross; K I Taylor; A P Yung; P D Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

Review 2.  Herpes latency, meningitis, radiculomyelopathy and disseminated infection.

Authors:  J J Sasadeusz; S L Sacks
Journal:  Genitourin Med       Date:  1994-12

3.  Retrospective diagnosis of fatal herpes simplex myelitis by immunocytochemistry and polymerase chain reaction.

Authors:  C E Clarke; P M Crawford; A M Clarke; D Dockey; L R Bridges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

4.  Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes.

Authors:  Quanhathai Kaewpoowat; Lucrecia Salazar; Elizabeth Aguilera; Susan H Wootton; Rodrigo Hasbun
Journal:  Infection       Date:  2015-12-17       Impact factor: 3.553

Review 5.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

Review 6.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

7.  Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans.

Authors:  Alon Schneider Hait; David Olagnier; Vanessa Sancho-Shimizu; Kristian Alsbjerg Skipper; Marie Helleberg; Simon Muller Larsen; Chiranjeevi Bodda; Liviu Ionut Moldovan; Fanghui Ren; Nanna-Sophie Brinck Andersen; Michelle M Thomsen; Mette Ratzer Freytag; Sathya Darmalinggam; Isobel Parkes; Darshana D Kadekar; Stine Hess Rahbek; Demi van der Horst; Lasse Sommer Kristensen; Kristina Eriksson; Jørgen Kjems; Serge Mostowy; Mette Christiansen; Jacob Giehm Mikkelsen; Christian Thomas Brandt; Søren R Paludan; Trine H Mogensen
Journal:  Sci Immunol       Date:  2020-12-11

Review 8.  Viral meningitis: an overview.

Authors:  Amira Kohil; Sara Jemmieh; Maria K Smatti; Hadi M Yassine
Journal:  Arch Virol       Date:  2021-01-03       Impact factor: 2.685

9.  Recurrent lymphocytic meningitis positive for herpes simplex virus type 2.

Authors:  Katariina Kallio-Laine; Mikko Seppänen; Hannu Kautiainen; Marja Liisa Lokki; Maija Lappalainen; Ville Valtonen; Markus Färkkilä; Eija Kalso
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

10.  Clinical and Laboratory Findings That Differentiate Herpes Simplex Virus Central Nervous System Disease from Enteroviral Meningitis.

Authors:  Layli Sanaee; Monica Taljaard; Tim Karnauchow; Jeffrey J Perry
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-08-01       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.